Objective: The aim of this study was to determine the frequency of cry
oglobulinemia and associated symptoms in transfusion-dependent thalass
emia patients at high risk for HCV infection. Methods: A controlled ep
idemiological study was used to evaluate the prevalence of clinical, b
iochemical and immunological abnormalities in a group of 264 HCV-posit
ive and 106 HCV-negative transfusion-dependent thalassemia patients. H
aematologic and hepatic function tests were performed according to sta
ndard methods. HCV-RNA was detected by PCR analysis. Results: The sign
ificant presence of cryoglobulinemia and associated symptoms (purpura,
vasculitis, arthritis, asthenia, proteinuria), serum autoantibodies (
SMA, anti-GOR, ANA, LKM), low complement and rheumatoid factor were fo
und in HCV-positive compared with HCV-negative patients. Conclusions:
This study demonstrates the role of HCV in inducing cryoglobulinemia a
nd immunological disorders in transfusion-dependent thalassemia patien
ts. HCV infection and associated immune abnormalities are a new clinic
al aspect of, and deserve particular attention due to their high frequ
ency in, transfusion-dependent thalassemia patients.